Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 20/20 | 0.74 |
| ▸ | SCTR | P47872 | 1/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30377221 | 0.99 | GLP1R (0.75) | GLP1RSCTR | |
| SCHEMBL29800085 | 0.99 | GLP1R (0.75) | GLP1RSCTR | |
| SCHEMBL30428145 | 0.99 | GLP1R (0.75) | GLP1RSCTR | |
| SCHEMBL29462130 | 0.99 | GLP1R (0.75) | GLP1RSCTR | |
| SCHEMBL29799938 | 0.99 | GLP1R (0.75) | GLP1RSCTR | |
| SCHEMBL30377709 | 0.99 | GLP1R (0.75) | GLP1RSCTR | |
| SCHEMBL31406266 | 0.99 | GLP1R (0.75) | GLP1RSCTR | |
| SCHEMBL29800188 | 0.99 | GLP1R (0.75) | GLP1RSCTR | |
| SCHEMBL30987835 | 0.98 | GLP1R (0.75) | GLP1RSCTR | |
| SCHEMBL30378098 | 0.98 | GLP1R (0.73) | GLP1RSCTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111944039-B | Synthetic method of somalupeptide | 深圳市健元医药科技有限公司 | 2024-09-06 | — | — | CN | disclosed |
| CN-113637064-B | Synthetic method of somalupeptide | 深圳市健翔生物制药有限公司 | 2023-11-28 | — | — | CN | disclosed |
| CN-113423723-B | Preparation method of somalupeptide | 深圳市健元医药科技有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-111944038-B | Synthetic method of somalupeptide | 深圳市健元医药科技有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-111944037-B | Synthetic method of somalupeptide | 深圳市健元医药科技有限公司 | 2023-06-13 | — | — | CN | disclosed |
| CN-112010961-B | Solid-liquid synthesis method of somalupeptide | 深圳市健元医药科技有限公司 | 2023-05-16 | — | — | CN | disclosed |
| US-20230133716-A1 | PREPARATION METHOD FOR SEMAGLUTIDE | Shenzhen JYMed Technology Co., Ltd. (CN) | 2023-05-04 | — | — | US | disclosed |
| CN-113135991-B | Method for preparing somaglutide | 深圳市健元医药科技有限公司 | 2023-04-07 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230133716-A1 | PREPARATION METHOD FOR SEMAGLUTIDE | GCG, GLP1R, DPP7 | GLP1R 2/4885SCTR 476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.